Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RNLX

Renalytix (RNLX) Stock Price, News & Analysis

Renalytix logo

About Renalytix Stock (NASDAQ:RNLX)

Advanced Chart

Key Stats

Today's Range
$0.19
$0.23
50-Day Range
$0.18
$0.30
52-Week Range
$0.18
$2.40
Volume
934,496 shs
Average Volume
1.45 million shs
Market Capitalization
$17.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RNLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter.

RNLX Stock News Headlines

Renalytix Adjusts Share Capital Amid Fundraising Shortfall
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

RNLX Stock Analysis - Frequently Asked Questions

Renalytix Plc (NASDAQ:RNLX) posted its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.11) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.11). The company earned $0.46 million during the quarter, compared to the consensus estimate of $0.70 million.

Renalytix (RNLX) raised $156 million in an IPO on Friday, July 17th 2020. The company issued 11,000,000 shares at a price of $14.22 per share. J.P. Morgan and Stifel acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Renalytix investors own include Invesco QQQ (QQQ), SPDR Dow Jones Industrial Average ETF Trust (DIA), SPDR S&P 500 ETF Trust (SPY), NVIDIA (NVDA), CrowdStrike (CRWD), Broadcom (AVGO) and Meta Platforms (META).

Company Calendar

Last Earnings
11/14/2023
Today
7/17/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:RNLX
CIK
1811115
Fax
N/A
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.39)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$33.46 million
Net Margins
-1,461.60%
Pretax Margin
-1,461.42%
Return on Equity
N/A
Return on Assets
-281.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.53
Quick Ratio
0.53

Sales & Book Value

Annual Sales
$2.29 million
Price / Sales
7.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.10) per share
Price / Book
-2.07

Miscellaneous

Outstanding Shares
82,960,000
Free Float
63,059,000
Market Cap
$17.18 million
Optionable
Optionable
Beta
2.72

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:RNLX) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners